Bioequivalence Study of Nateglinide Tablets 120 mg of Dr. Reddy's Laboratories Limited Under Fasting Condition
Status:
Completed
Trial end date:
2007-02-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to compare the rate and extent of absorption of nateglinide
120 mg tablet (test) versus Starlix ® (reference), administered as 1 x 120 mg tablet under
fasting conditions.